|
|||||
|
|
Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study) |
|
| Authors: | Mohit K. Turagam MD Valay Parikh MD Muhammad R. Afzal MD Rakesh Gopinathannair MD Madhav Lavu MD Arun Kanmanthareddy MD Jayasree Pillarisetti MD Madhu Reddy MD Donita Atkins RN Sudharani Bommana MSc Melissa Jaeger RN Courtney Jeffery NP Sanghamitra Mohanty MD Pasquale Santangeli MD Jie Cheng MD Luigi Di Biase MD Calambur Narasimhan MD Andrea Natale MD Dhanunjaya Lakkireddy MD |
| Affiliation: | 1. Division of Cardiovascular Medicine, University of Missouri Hospital and Clinics, Columbia, MO, USA;2. Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital & Medical Center, Kansas City, KS, USA;3. Section of Electrophysiology, University of Louisville, Louisville, KY, USA;4. Creighton Universtiy, Omaha, NE, USA;5. Electrophysiology Associates, Dallas, TX, USA;6. Texas Cardiac Arrhythmia Institute, Austin, TX, USA;7. Section of Electrophysiology, University of Pennsylvania, Philadelphia, PA, USA;8. University of Texas Houston, Houston, TX, USA;9. Montefiore Medical Center, Bronx, NY, USA;10. Care Hospital, Hyderabad, Telangana, India |
| Abstract: | |
| Keywords: | direct oral anticoagulant left atrial appendage major bleeding systemic thromboembolism thrombus warfarin intolerance |